| Block Listing Return | 02-Jan-2026 | ShareCast |
| Oxford Biomedica acquires US viral vector facility | 07-Oct-2025 | ShareCast |
| Oxford Biomedica reiterates outlook as interim l... | 23-Sep-2025 | ShareCast |
| RBC Capital Markets raises target price on OXB | 26-Aug-2025 | ShareCast |
| Oxford Biomedica raises £60m to bolster US capac... | 15-Aug-2025 | ShareCast |
| Total Voting Rights | 02-Jan-2026 | 07:00 | RNS |
| Block Listing Return | 02-Jan-2026 | 07:00 | RNS |
| Block Listing Return | 02-Jan-2026 | 07:00 | RNS |
| Total Voting Rights | 02-Jan-2026 | 07:00 | RNS |
| PDMR Dealing | 08-Dec-2025 | 15:15 | RNS |
| Need to know: Opec cuts forecast ... Tesco cuts ... | 16-Aug-2008 | Times |
| Need to know | 10-May-2008 | Times |
| DSG International may be losing its spark | 12-Feb-2008 | Telegraph |
| Oxford BioMedica clinches $690m licensing deal f... | 29-Mar-2007 | The Independent |
| Oxford Biomedica seals €518m deal with Sanofi ov... | 29-Mar-2007 | Times |
No recent information was found.
| Currency | UK Pounds |
| Share Price | 663.00p |
| Change Today | 8.00p |
| % Change | 1.22 % |
| 52 Week High | 682.00p |
| 52 Week Low | 232.50p |
| Volume | 437,396 |
| Shares Issued | 120.75m |
| Market Cap | £800.59m |
| Beta | 1.78 |
| RiskGrade | 125 |
| Value |
|
|---|
| Price Trend |
|
|---|
| Income | ![]() |
|---|
| Growth |
|
|---|
| Strong Buy | 5 |
| Buy | 2 |
| Neutral | 3 |
| Sell | 0 |
| Strong Sell | 0 |
| Total | 10 |

| No dividends found |
| Time | Volume / Share Price |
| 17:07 | 1,000 @ 663.00p |
| 16:47 | 3,609 @ 664.00p |
| 16:38 | 33,655 @ 663.00p |
| 16:37 | 91 @ 663.00p |
| 16:37 | 493 @ 663.00p |
| Chair | Roch Doliveux |
| CEO | Frank Mathias |
| CFO | Lucinda (Lucy) Crabtree |
You are here: research